Anzu Partners

Anzu Partners is a venture capital and private equity firm founded in 2014 by Whitney Haring-Smith, David Michael, and David Seldin. Headquartered in Washington, D.C., the firm specializes in early-stage investments in industrial and life science technology companies across the United States and Canada. Anzu Partners collaborates with entrepreneurs to develop and commercialize innovative technologies, providing not just capital but also expertise in business development, market positioning, and global connectivity. The firm focuses on breakthrough industrial technologies with transformative potential, aiming to foster long-term relationships that drive results beyond initial investments.

Jenna Abelli

Principal, Investments

Chris Birmingham

Associate

Henk Both

Principal, Investments

Gautham Chandrasekar

Investor

Aaron Delahanty

Associate

Whitney Haring-Smith

Managing Partner

Patrick Harrington

Principal, Fund Finance

Matthew Hurst

Associate

Logan Jackson

Senior Associate

Jimmy Kan

Investment Partner

Abhiram Kannan

Investor

Ed Liddy

Venture Partner

Tawanda Mahachi

Associate

Jaione Maiz Ph.D

Principal, Investor

Sonal Naik

Investment Director

Luke O'Hare

Associate

Cathryn Paine

Partner, People

Donald Rosenberg

Venture Partner

Katrina Sample

Analyst

Tayo Sanders II

Investor

David Seldin

Managing Partner and Co-Founder

Sashank Shivakumar

Analyst

Kritika Singh

Associate

Ben Slotkin

Analyst

Josh Stiling

Investor

William Strong

Partner

Mollie Wilkinson

Investor

Alan Yang

Associate

Past deals in Albuquerque, NM

BioFlyte

Series A in 2022
BioFlyte specializes in the development of advanced bio-threat detection devices aimed at safeguarding against biological and low-volatility chemical threats. The company's innovative aerosol mass spectrometers are capable of autonomously sampling ambient air in critical environments, while also allowing for the manual analysis of liquid or powder samples. These instruments can identify a range of threats, including microbes, bio-toxins, and airborne chemicals, providing timely alerts to users about potential dangers. BioFlyte's technologies are designed to enhance safety and security by enabling effective responses to bio-chemical risks.

BioFlyte

Seed Round in 2020
BioFlyte specializes in the development of advanced bio-threat detection devices aimed at safeguarding against biological and low-volatility chemical threats. The company's innovative aerosol mass spectrometers are capable of autonomously sampling ambient air in critical environments, while also allowing for the manual analysis of liquid or powder samples. These instruments can identify a range of threats, including microbes, bio-toxins, and airborne chemicals, providing timely alerts to users about potential dangers. BioFlyte's technologies are designed to enhance safety and security by enabling effective responses to bio-chemical risks.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.